Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy

机译：Pegfilgrastim预防TAC化疗的乳腺癌患者发热性中性粒细胞减少

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposePrimary prophylaxis with granulocyte colony-stimulating factor can effectively prevent febrile neutropenia (FN) during breast cancer treatment. The aims of this study were to evaluate the incidence of FN and the ANC profile in patients undergoing chemotherapy and pegfilgrastim primary prophylaxis.

机译：目的初步预防粒细胞集落刺激因子可有效预防乳腺癌治疗期间的发热性中性粒细胞减少症（FN）。这项研究的目的是评估接受化疗和培非非司亭初步预防的患者中FN的发生率和ANC分布。

著录项

期刊名称 Annals of Surgical Treatment and Research
作者
Jihyoun Lee; Jong Eun Lee; Zisun Kim; Sun Wook Han; Sung Mo Hur; Sung Yong Kim; Min Hyuk Lee; Cheol Wan Lim;
展开▼
作者单位

展开▼
年(卷),期 2018(94),5
年度 2018
页码 223–228
总页数 6
原文格式 PDF
正文语种
中图分类外科学;
关键词
Breast neoplasms Adjuvant chemotherapy Febrile neutropenia Granulocyte colony-stimulating factor;

机译：乳腺肿瘤;辅助化疗;发热性中性粒细胞减少;粒细胞集落刺激因子;
入库时间 2022-08-17 16:08:27

相似文献

外文文献
中文文献
专利

1. Pegfilgrastim vs filgrastim in primary prophylaxis of febrile neutropenia in patients with breast cancer after chemotherapy: a cost-effectiveness analysis for Germany [J] . Sehouli J, Goertz A, Steinle T, DMW: Deutsche Medizinische Wochenschrift . 2010,第9期

机译：Pegfilgrastim vs filgrastim初步预防化疗后乳腺癌患者发热性中性粒细胞减少症：德国的成本-效果分析
2. Risk of febrile neutropenia as a function of age and disease stage in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropenia management – results from the NeuCuP analysis [J] . M.Aapro, M.Schwenkglenks, G.Lyman, European Journal of Cancer Supplements . 2008,第7期

机译：接受pegfilgrastim一级预防与目前实践中性粒细胞减少症管理的乳腺癌患者的发热性中性粒细胞减少症风险随年龄和疾病阶段的变化而变化–来自NeuCuP分析的结果
3. Risk of febrile neutropenia as a function of age and disease stage in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropenia management – results from the NeuCuP analysis [J] . M.Aapro, M.Schwenkglenks, G.Lyman, European Journal of Cancer Supplements . 2008,第7期

机译：接受pegfilgrastim一级预防与目前实践中性粒细胞减少症管理的乳腺癌患者的发热性中性粒细胞减少症风险随年龄和疾病阶段的变化而变化–来自NeuCuP分析的结果
4. Prognostic Significance of COX-2 and VEGF in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy [C] . Gang-Ping WANG, Xue WANG, Zhao-Jun DING, International Conference on Biological Sciences and Technology . 2016

机译：Cox-2和VEGF在接受新辅助化疗的乳腺癌患者中的预后意义
5. Effects of primary prophylaxis of neutropenia on outcomes, utilization and expenditures for elderly breast cancer patients receiving chemotherapy. [D] . Rajan, Suja S. 2009

机译：一级预防中性粒细胞减少对老年接受化疗的乳腺癌患者的结局，利用和支出的影响。
6. Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy [O] . Xiao Jun Wang, Tiffany Tang, Mohamad Farid, -1

机译：对于非霍奇金淋巴瘤患者采用药性相似的粒细胞集落刺激因子（Nivestim）或培格非司汀常规预防发热性中性粒细胞减少是成本有效的接受治疗性R-CHOP化疗
7. Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy [O] . Jihyoun Lee, Jong Eun Lee, Zisun Kim, 2018

机译：在接受TAC化疗的乳腺癌患者中发热中性粒细胞减少症的主要预防的PEGFILGRASIM
8. Psychological Stress, Neutropenia and Infectious Disease in Patients Receiving Chemotherapy Treatment for Breast Cancer [R] . Bovbjerg, D. 1999

机译：乳腺癌化疗治疗患者的心理应激，中性粒细胞减少和传染病

Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅